Brief: Bioxcel Therapeutics Submits Pre-Supplemental New Drug Application Meeting Package In Support Of Potential Label Expansion For Igalmi
21/07/2025 12:02
July 21 (Reuters) - BioXcel Therapeutics Inc BTAI.O: BIOXCEL THERAPEUTICS SUBMITS PRE-SUPPLEMENTAL NEW DRUG APPLICATION MEETING PACKAGE IN SUPPORT OF POTENTIAL LABEL EXPANSION FOR IGALMI® BIOXCEL THERAPEUTICS INC - PRE-SNDA MEETING WITH FDA SCHEDULED FOR AUGUST 20, 2025 Source text: ID:nGNXbhXhYX Further company coverage: BTAI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioXcel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna
Brief: Bioxcel Therapeutics Enters Into Asset Sale Agreement With Teva Pharmaceuticals
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna, Ulta Beauty